We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 5,617 results
  1. Botulinum Neurotoxins for Relief of Pain Associated with Spasticity

    Spasticity is a common and disabling complication of stroke, multiple sclerosis, brain and spinal cord injury, neurogenetic disorders, and cerebral...
    Chapter 2022
  2. Light Chain Role in Action of Botulinum Toxins/Clostridial Neurotoxins

    The clostridial neurotoxins (CNT), botulinum neurotoxins (BT) and tetanus neurotoxin (TT), are the most toxic protein toxins for humans. BT isolates...
    Alexander Gardner, Joseph T. Barbieri in Handbook of Neurotoxicity
    Living reference work entry 2021
  3. Botulinum Neurotoxins as a Therapeutic

    Since first recognized as the cause of food-borne botulism in the early nineteenth century, botulinum toxin was suggested as a potential treatment...
    Raja Mehanna, Joseph Jankovic in Handbook of Neurotoxicity
    Reference work entry 2022
  4. Beyond Botox: Other Neurotoxins—What Are Similarities and Differences?

    This chapter describes the pharmacological and clinical characteristics of six botulinum toxins—Botox, Xeomin, Dysport, Myobloc, Jeuveau and...
    Bahman Jabbari in Botulinum Toxin Treatment
    Chapter 2024
  5. Botulinum Neurotoxins: Mechanism of Action

    Botulinum neurotoxins (BoNTs) are a growing family of bacterial protein toxins that cause botulism, a rare but often fatal animal and human disease....
    O. Rossetto, M. Pirazzini, ... C. Montecucco in Botulinum Toxin Therapy
    Chapter 2020
  6. Susceptibility of GPCR Heteroreceptor Complexes to Neurotoxins. Relevance for Neurodegenerative and Psychiatric Disorders

    G protein-coupled receptors (GPCRs) possess significant patterns of intrinsic unfolding. GPCRs have similarities to proteins that have a high net...
    Dasiel O. Borroto-Escuela, Rasiel Beltran-Casanueva, ... Kjell Fuxe in Handbook of Neurotoxicity
    Living reference work entry 2022
  7. Susceptibility of GPCR Heteroreceptor Complexes to Neurotoxins. Relevance for Neurodegenerative and Psychiatric Disorders

    G protein-coupled receptors (GPCRs) possess significant patterns of intrinsic unfolding. GPCRs have similarities to proteins that have a high net...
    Dasiel O. Borroto-Escuela, Rasiel Beltran-Casanueva, ... Kjell Fuxe in Handbook of Neurotoxicity
    Reference work entry 2022
  8. Botulinum Neurotoxins

    Ornella Rossetto, Cesare Montecucco in Encyclopedia of Molecular Pharmacology
    Living reference work entry 2020
  9. Botulinum Neurotoxins as a Therapeutic

    Since first recognized as the cause of food-borne botulism in the early nineteenth century, botulinum toxin was suggested as a potential treatment...
    Raja Mehanna, Joseph Jankovic in Handbook of Neurotoxicity
    Living reference work entry 2021
  10. How Do Bacterial Neurotoxins Affect Neurosecretion?

    The mechanism by which bacterial toxins alter or interfere with secretion mechanisms are addressed in this chapter. After a brief description of the...
    Bernard Poulain, Frédéric Doussau in Neurosecretion: Secretory Mechanisms
    Chapter 2020
  11. Psychoactive Medicinal Plants and Fungal Neurotoxins

    This book provides a clear and comprehensive overview of psychoactive medicinal plants, explaining in detail the species that are most commonly used...

    Amritpal Singh Saroya, Jaswinder Singh
    Book 2020
  12. Autism Spectrum Disorder Initiation by Inflammation-Facilitated Neurotoxin Transport

    Autism spectrum disorders have been linked to genetics, gut microbiota dysbiosis (gut dysbiosis), neurotoxin exposures, maternal allergies or...

    Kevin Roe in Neurochemical Research
    Article 20 January 2022
  13. Molecular Structure and Mechanisms of Action of Botulinum Neurotoxins

    Botulinum neurotoxins (BoNTs) are a growing family of bacterial protein toxins that cause a generalized flaccid paralysis of botulism by inactivating...
    Chapter 2020
  14. Novel Native and Engineered Botulinum Neurotoxins

    Botulinum neurotoxins (BoNTs), produced by Clostridia and other bacteria, are the most potent toxins known. Their cleavage of the soluble...
    Lance Steward, Mitchell F. Brin, Amy Brideau-Andersen in Botulinum Toxin Therapy
    Chapter 2020
  15. Handbook of Neurotoxicity

    This handbook is a reference source for identifying, characterizing, instructing on use, and describing outcomes of neurotoxin treatments – to...
    Richard M. Kostrzewa
    Reference work 2022
  16. The History of Botulinum Neurotoxin Development

    This chapter provides information on the history and development of botulinum neurotoxins as a therapeutic tool in clinical medicine. It discusses...
    Chapter 2022
  17. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation

    Dystonia is a complex disorder with numerous presentations occurring in isolation or in combination with other neurologic symptoms. Its treatment has...

    Ian O. Bledsoe, Aaron C. Viser, Marta San Luciano in Neurotherapeutics
    Article 23 October 2020
  18. Botulinum Toxin Treatment What Everyone Should Know

    This book explains and discusses in simple language the structure and function of botulinum toxin and other neurotoxins as well as the rational for...

    Bahman Jabbari
    Book 2024
  19. The Emerging Role of Astrocytic Autophagy in Central Nervous System Disorders

    Astrocytes act as “housekee** cells” for maintaining cerebral homeostasis and play an important role in many disorders. Recent studies further...

    Zhuchen Zhou, **g Zhou, ... Yanrong Zheng in Neurochemical Research
    Article 12 August 2022
  20. Diverse and Dynamic Alpha-Neurotoxicity Within Venoms from the Palearctic Viperid Snake Clade of Daboia, Macrovipera, Montivipera, and Vipera

    The targeting of specific prey by snake venom toxins is a fascinating aspect of molecular and ecological evolution. Neurotoxic targeting by elapid...

    Abhinandan Chowdhury, Christina N. Zdenek, Bryan G. Fry in Neurotoxicity Research
    Article Open access 04 October 2022
Did you find what you were looking for? Share feedback.